If you enjoyed this talk, consider joining the Molecular Modeling and Drug Discovery (M2D2) talks live: https://valence-discovery.github.io/M...
Also consider joining the M2D2 Slack: https://join.slack.com/t/m2d2group/sh...
Abstract: Combining drugs opens new possibilities for tailoring therapies to a given disease and targeting several biological pathways at the same time. However the number of possible drug combinations is huge, and only a tiny portion of this space can be explored in a reasonable amount of time. One could either narrowly focus on experimenting with a very restricted number of well-chosen drugs, based on pre-existing biological knowledge, or broaden the scope by exploring uncharted territories with the risk of very low time and cost efficiency.
Speaker: Paul Bertin - https://bertinus.github.io/
Twitter Prudencio: https://twitter.com/tossouprudencio
Twitter Therence: https://twitter.com/Therence_mtl
Twitter Cas: https://twitter.com/cas_wognum
Twitter Valence Discovery: https://twitter.com/valence_ai
Fler avsnitt av Molecular Modelling and Drug Discovery
Visa alla avsnitt av Molecular Modelling and Drug DiscoveryMolecular Modelling and Drug Discovery med Valence Discovery finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
